Health

Myrkl - The NEW Liver Function and Detox Support Supplement that sold out in 24hrs

Enjoy socialising without sacrificing the next day! AUCKLAND, New Zealand, Nov. 2, 2023 /PRNewswire/ -- Myrkl (pronounced myr-a-kle)is the new liver function and detox support supplement that is taking the world by storm. This innovative supplement contains patented AB001™ which activates i...

2023-11-02 11:25 1685

Fonterra shares New Zealand's best farming practices to upskill Thai dairy farmers

PAK CHONG, Thailand, Nov. 2, 2023 /PRNewswire/ -- New Zealand's largest dairy co-operative, Fonterra joined hands today with the Thai government to help upskill Thai dairy farmers and improve local farming practices. The 3-day dairy development program currently underway at the Nakornratchashima...

2023-11-02 11:22 1913

Chula Launches the Latest Parkinson's Gloves to Reduce Tremors

BANGKOK, Nov. 2, 2023 /PRNewswire/ -- Chula   medical researchershave developed lightweight and easy-to-use Parkinson's gloves that can automatically reduce tremors, allowing Parkinson's Disease patients to enjoy social life and reducing side effects from medication an...

2023-11-02 10:00 1795

TraceLink MINT Wins 2023 Pharma Innovation Award: 100% End-to-End Supply Chain Digitalization is Now Within Reach

100% End-to-End Supply Chain Digitalization is Now Possible with Proven Network Orchestration Capability BOSTON, Nov. 2, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 291,000 healthcare and life...

2023-11-02 05:22 1750

Treasure Global's ZCITY App Signs a Memorandum of Understanding with Malaysia's Leading Healthcare Group, UCSI Hospital, to Pioneer Stem Cell Healthcare Tourism for Indonesia, Hong Kong and Mainland China

- Through this partnership, TGL will further monetize its user base and expects a projected 100%monthly gross profit increase from this partnership - NEW YORK and KUALA LUMPUR, Malaysia, Nov. 1, 2023 /PRNewswire/ -- Treasure Global Inc (NASDAQ: TGL) ("TGL," "Treasure Global" or the "Company"), an...

2023-11-01 22:53 1830

Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction

The Group is Advancing the Program to a Phase II Clinical Study Data presented at the 2023 Fall Clinical Dermatology Conference HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, Nov. 1, 2023 /PRNewswire/ --Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries,...

2023-11-01 22:07 2180

Johnson & Johnson Innovation Launches Singapore QuickFire Challenge with the Singapore Economic Development Board

Following launch of first-of-its-kind collaboration between Johnson & Johnson Innovation – JLABS andSingapore's Economic Development Board, the Singapore QuickFire Challenge invites innovators to pitch for grant funding from a pool of $100,000 for further development. SINGAPORE, Nov. 1, 2023 /PRN...

2023-11-01 22:05 2095

Milliken & Company Launches OVIK Health

Company rebrands healthcare business as a strategic enabler SPARTANBURG, S.C., Nov. 1, 2023 /PRNewswire/ -- Today, global diversified manufacturer Milliken & Company unveiled a new brand platform for its healthcare business. OVIK Health, as Milliken Healthcare Products, LLC, will now be known, r...

2023-11-01 21:38 2298

SIBIONICS Achieves Milestone: Receiving CE Mark for Its Groundbreaking GS1 Continuous Glucose Monitoring System

SHENZHEN, China, Nov. 1, 2023 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring System (CGM) brand, is delighted to announce that it has received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, fac...

2023-11-01 20:28 3105

CStone Announces Strategic Partnership and Exclusive Licensing Agreement with 3SBio for Nofazinlimab (Anti-PD-1 Antibody) in Mainland China

* CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in mainlandChina. CStone to retain the rights to nofazinlimab outside mainland China. * This partnership will combine the strengths of CStone a...

2023-11-01 18:10 3354

AXA BetterMe Weekend concludes in high note, drawing over 12,000 participants

Two-day carnival inspires physical and mental well-being Allowing citizens to unwind and rejuvenate to become a BetterMe HONG KONG, Nov. 1, 2023 /PRNewswire/ -- AXA BetterMe Weekend, the iconic annual carnival hosted by AXA Hong Kong andMacau (AXA) on 28 and 29 October 2023, was a resounding succ...

2023-11-01 18:02 2102

Herbalife Survey Reveals More Than Half of Asia Pacific Consumers Find Support Groups Very Important in Their Health and Wellness Journeys

Herbalife Run returns this November to celebrate the power of community for supporting healthy, active living HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released findings from itsAsia Pacific Power of Community Survey,revealing t...

2023-11-01 15:38 2974

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

* 1 in 2 Diabetics and 1 in 10 Pre-diabetics estimated to suffer from Peripheral Neuropathy * Vitamin B Deficiency affects quality of life of ~ 19% of all people with diabetes * #KnowtheSigns leverages Artificial Intelligence to make the invisible condition of Peripheral Neuropathy & Vitami...

2023-11-01 14:00 1970

New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health

JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- A new report from JPA Health entitled, "One World, One Health: Exploring the Connectability between Human, Animal and Environmental Health," reveals a concerning lack o...

2023-11-01 12:01 1696

Extracellular Nanoparticles Sourced From Another Species Reverses Biological Age of Rats by More Than 50%

Peer Reviewed Publication: World's first demonstration of cross species epigenetic transfer that significantly reverses biological age by Scientists at Yuvan Research. MOUNTAIN VIEW, Calif., Nov. 1, 2023 /PRNewswire/ -- In a groundbreaking research paper titled"Reversal of Biological Age in Mult...

2023-11-01 09:14 1236

Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata

LONDON, Nov. 1, 2023 /PRNewswire/ -- Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata.  Final results of the study are anticipated to be ...

2023-11-01 09:05 1064

Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting

SHANGHAI and HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer...

2023-11-01 08:30 1561

88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions

SHENZHEN, China, Oct. 31, 2023 /PRNewswire/ -- The 88th China International Medical Equipment Fair (CMEF) officially kicks off onOctober 28 at the Shenzhen World Exhibition & Convention Center. The four-day tradeshow will feature over 10,000 products brought by over 4,000 exhibitors from more tha...

2023-10-31 21:34 2242

BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures

NEW YORK, Oct. 31, 2023 /PRNewswire/ -- MSQ Ventures ("MSQ") is pleased to announce that its client, BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has entered into an exclusive license agreement with Guangzhou Gloria Biosciences Co., Ltd. (GloriaBio) and an associated investor for the deve...

2023-10-31 21:00 3294

YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

GAITHERSBURG, Md., Oct. 31, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-10-31 20:30 1474
1 ... 106107108109110111112 ... 580

Week's Top Stories